GlassScriptPrepare for your visit
Rachel E Mould
Physician Assistant · Youngstown, OH · NPI 1730546599
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$180.59
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Salix Pharmaceuticals, A Division of Bausch Health US, LLC $31.19
- Lilly USA, LLC $29.48
- Astrazeneca Pharmaceuticals LP $24.68
- Amarin Pharma, INC. $21.57
- Janssen Pharmaceuticals, INC $19.77
- Merck Sharp & Dohme LLC $14.82
Drugs and devices associated with these payments
Vascepa Trulance Xifaxan Mounjaro Eliquis Paxlovid Nurtec Odt
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Rachel Mould listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11131950/rachel-e-mould